$GL

Kalmbach Thomas Peter sold $4.6M of GL

Kalmbach Thomas Peter (EVP & CFO) sold 25,650 shares of GLOBE LIFE INC. (GL) at an average of $178.58 ($178.06–$179.42, $4.58M total) across 3 trades on 2026-07-28.

Original reporting
SEC EDGAR · Kalmbach Thomas Peter
Published Jul 29, 2026, 10:27 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$GL
Neutral
medium confidence
Mentioned
$GL
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GLNeutralLow
01

Why it matters

The disclosure updates the market on insider selling activity and the CFO’s remaining direct holdings, but it does not provide new company fundamentals.

02

Market read

Traders may monitor GL for sentiment effects from insider selling, but there is no new operational or financial catalyst in the text.

03

What to watch

The absence of a stated 10b5-1 plan can increase attention, but the filing still lacks any stated reason for the sale or linkage to company performance.

Relevance 6/10Novelty 3/10Timing: filed after-hours on 2026-07-29 for trades dated 2026-07-28

Background

The article is an SEC Form 4 insider transaction report for Globe Life Inc. (GL).

Company-level read

Ticker impact

$GLNeutralMedium confidence
Context

Kalmbach Thomas Peter, GL’s EVP and CFO, sold 25,650 shares in open-market trades for about $4.58M on 2026-07-28.

Expected impact

Likely limited near-term impact; traders may view it as modestly bearish sentiment but not a fundamental catalyst.

Evidence & confidence

Form 4 provides transaction details (size, price range, post-sale holdings) but the filing does not disclose new guidance, contracts, or business developments.

Market effects

No clear sector read-through; this is an issuer-specific insider transaction.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs, so the signal may be weak.

Key entities

  • Globe Life Inc.

    Subject of the Form 4 insider sale by its EVP and CFO.

  • Kalmbach Thomas Peter

    EVP and CFO who sold 25,650 shares in open-market transactions.

Related articles

$GLMedAI 8/10

Globe Life Boosts EPS Outlook Following Strong Q2 Earnings

Globe Life Inc. reported Q2 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. The insurer cited underwriting strength and excess investment returns and raised full-year guidance to 2026 net operating EPS of $15.55-$15.95 and share repurchases of $670M-$700M.

$GLMed

Why Globe Life (GL) Shares Are Sliding Today

Globe Life (NYSE: GL) shares fell about 7% after its Q2 results met Wall Street estimates but did not provide upside. Revenue rose 6.7% to about $1.6B and net premiums earned were about $1.30B. GAAP EPS was $3.65 vs $3.64 expected. The stock closed at $170.96.

$GLMedAI 8/10

Full Transcript: Globe Life Q2 2026 Earnings Call - Globe Life (NYSE:GL)

Globe Life Inc. (NYSE:GL) reported Q2 2026 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. Premium revenue rose 7% (life +3%, health +16%). The company repurchased $175 million of shares and guided full-year net operating EPS growth of 8.5%.

$GLMedAI 8/10

Globe Life Q2 Earnings Call Highlights

Globe Life (NYSE:GL) reported Q2 health premium revenue up 16% to $437M and health underwriting margin up 1% to $99M, though the margin fell to about 23%. Life policy obligations improved. Management raised 2026 net operating EPS guidance to $15.55 to $15.95 and increased buybacks. The company repurchased ~1.1M shares for $175M in Q2.

$GLMedAI 8/10

Why is Globe Life stock sliding today? By Investing.com

Globe Life shares fell 8.1% after its Q2 2026 results. Net operating income was $3.61 per diluted share versus $3.67 consensus, while revenue was $1.60B versus $1.59B. Full-year 2026 EPS guidance was raised to $15.55-$15.95 but the midpoint ($15.75) stayed below $15.65 consensus, alongside insider net selling and a risk-off market.

$GLMed

GLOBE LIFE INC. (GL): Results of Operations and Financial Condition

GLOBE LIFE INC. (GL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q2fy2026earningsrelease.htm EX-99.1 Document GLOBE LIFE INC. REPORTS Second Quarter 2026 Results McKinney, TX, July 22, 2026 —Globe Life Inc. (NYSE: GL) reported today that for the quarter ended June 30, 2026, net income was $3.65 per diluted common share, compared with